Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

PMO MEDICAL PLLC

NPI: 1780054627 · BROKEN ARROW, OK 74012 · Pain Medicine (Physical Medicine & Rehabilitation) Physician · NPI assigned 10/05/2015

$3.15M
Total Medicaid Paid
83,219
Total Claims
79,180
Beneficiaries
54
Codes Billed
2018-01
First Month
2024-11
Last Month

Provider Details

Authorized OfficialHALFORD, JEFF (PHYSICIAN)
NPI Enumeration Date10/05/2015

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 26,494 $785K
2019 12,002 $435K
2020 10,998 $382K
2021 8,147 $330K
2022 8,555 $350K
2023 7,917 $385K
2024 9,106 $483K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 27,815 26,354 $1.21M
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 16,385 15,335 $876K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 20,487 19,122 $612K
99215 Prolong outpt/office vis 1,474 1,444 $78K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 844 843 $66K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 493 482 $56K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 605 603 $18K
82670 607 605 $17K
84403 605 603 $16K
82627 607 605 $14K
84270 607 605 $13K
80050 General health panel 296 296 $13K
83001 607 605 $11K
84481 608 606 $10K
83003 606 604 $10K
82533 605 603 $10K
86769 203 183 $9K
82607 540 538 $8K
82746 540 538 $8K
84144 347 345 $7K
86141 528 526 $7K
84480 454 452 $6K
84439 608 606 $5K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 57 57 $5K
83525 469 468 $5K
80061 Lipid panel 385 384 $5K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 300 289 $5K
82172 287 286 $5K
83090 287 286 $5K
84443 Thyroid stimulating hormone (TSH) 276 275 $5K
86800 287 286 $5K
83036 Hemoglobin; glycosylated (A1C) 456 455 $4K
84550 607 605 $3K
84436 362 360 $2K
80076 275 274 $2K
83735 309 308 $2K
82150 309 308 $2K
27096 14 14 $2K
86431 307 306 $2K
84402 65 65 $2K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 267 266 $2K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 72 70 $2K
84100 309 308 $1K
84152 65 65 $1K
96136 59 59 $1K
82947 275 274 $1K
85651 288 287 $1K
80305 104 96 $921.28
99442 23 23 $581.39
99441 22 22 $388.76
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 34 34 $197.87
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 57 26 $182.66
96127 85 85 $129.56
36416 36 36 $93.63